Clin2
NCT06836232Possibly a fitRecruiting

Study of VTX2735 for recurring pericarditis

Recurrent Pericarditis

Part of Heart & circulation clinical trials.

This trial tests an experimental drug called VTX2735 for people with recurring pericarditis (inflammation around the heart). It aims to see if the drug can help reduce pain and inflammation during a flare-up.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are between 18 and 75 years old.
  • You have had at least one prior episode of pericarditis that was confirmed.
  • You are currently having a symptomatic episode of pericarditis, or are expected to have one within the next month.
  • Your pain score from pericarditis is at least 4 out of 10.
  • If you take NSAIDs, colchicine, or steroids for pericarditis, your doses have been stable.
  • Your pericarditis is not caused by cancer, tuberculosis, injury, or other specific conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06708299Recruiting· Phase 3
CardiolRx for recurrent pericarditis

This trial tests if CardiolRx can help people with recurrent pericarditis (inflammation of the heart lining) who are stable on an IL-1 blocker and are planning to stop it. Researchers will see if CardiolRx can prevent a recurrence when the current treatment is tapered off.

Phoenix, Arizona
NCT07010159Recruiting· Phase 2/Phase 3
Study of KPL-387 for returning pericarditis

This study tests a new medicine, KPL-387, for people whose pericarditis keeps coming back despite standard treatments. It aims to see if this medicine can reduce flare-ups and help you feel better.

Gilbert, Arizona
NCT07288216Recruiting· Phase 2
Switching to KPL-387 alone for well-controlled pericarditis

This study tests whether a new drug, KPL-387, can keep your pericarditis under control as your only treatment, after you have been stable on other medicines. It is for people whose pericarditis is well controlled now but who have had flares in the past.

Phoenix, Arizona
NCT05925790Recruiting
Testing immune markers in recurring pericarditis

This study looks at immune blood markers to understand different types of recurring inflammation around the heart (pericarditis). The goal is to see whether certain marker patterns (like IL-1RA antibodies and suPAR) are linked to inflammation and what might be driving it.

Homburg
NCT06293924Enrolling by invitation
Testing fluid around the heart in recurring pericarditis

This study analyzes pericardial fluid (the fluid around your heart) to understand why pericarditis comes back. If you have pericarditis or other heart fluid buildup requiring drainage, or if you're having heart surgery, you may be able to participate.

Milan, Lombardy
NCT06658899Recruiting· Phase 2
Study of CRD-4730 for CPVT (rare heart rhythm disorder)

This study tests an experimental drug called CRD-4730 for people with CPVT, a rare inherited heart rhythm disorder that can cause dangerous fast heartbeats during exercise or stress. The trial will see if the drug can help control these abnormal heart rhythms better than current treatments.

San Francisco, California

Hear when a new Recurrent Pericarditis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.